UOC
DSCI

UBS O'Connor’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

UBS O'Connor’s Portfolio DSCI Stock Details DSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-30,000
Closed -$380K – 617
2014
Q1 		$380K Buy
+30,000
New +$388K 0.01% 370

Other funds holding DSCI

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

UBS O'Connor's DSCI Position: Q2 2014 in Review

UBS O'Connor sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q2 2014, closing a stake of 30,000 shares — an estimated $380K sold.

UBS O'Connor first reported a position in DSCI in Q1 2014 and held it in 1 quarter. The position peaked at $380K in Q1 2014. 73 funds tracked by Wall St. Rank hold DSCI as of Q2 2014.

  • UBS O'Connor reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q2 2014 after selling out during the quarter.
  • UBS O'Connor sold 30,000 Derma Sciences, Inc. Common Stock (DE) shares in Q2 2014, an estimated $380K.
  • UBS O'Connor first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q1 2014 and held it in 1 quarter.
  • UBS O'Connor's Derma Sciences, Inc. Common Stock (DE) position peaked at $380K in Q1 2014.
  • 73 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q2 2014.

Based on UBS O'Connor's 13F filing for Q2 2014, filed 15 Aug 2014.